Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in DHR — Danaher Corp /De/

CIK 1273087 NEW YORK, NY
Back to DHR Full portfolio

Position in DHR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$34,663,620
-$433,804,448 QoQ
Shares Held
182,825
-91.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Mar 31, 2026
CallValue
$8,626,800
CallShares
45,500
PutValue
$31,246,080
PutShares
164,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $798,894,531 across 31 Diagnostics & Research names. DHR ranks #8 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CRL
Charles River Laboratories International, Inc.
 934,045 $161,122,762
2 GH
Guardant Health, Inc.
 921,395 $85,109,256
3 A
Agilent Technologies, Inc.
 686,546 $78,252,513
4 WAT
Waters Corp /De/
 185,168 $55,143,030
5 IQV
Iqvia Holdings Inc.
 268,185 $45,736,269
6 IDXX
Idexx Laboratories Inc /De
 70,446 $39,582,902
7 TMO
Thermo Fisher Scientific Inc.
 70,696 $34,749,204
8 DHR
Danaher Corp /De/
This page 		182,825 $34,663,620

All Filings in DHR

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $31,246,080 164,800
2026-03-31 $34,663,620 182,825
2026-03-31 $8,626,800 45,500
2025-12-31 $44,158,668 192,900
2025-12-31 $19,091,928 83,400
2025-12-31 $468,468,068 2,046,427
2025-09-30 $25,179,020 127,000
2025-09-30 $183,901,019 927,575
2025-09-30 $19,310,524 97,400
2025-06-30 $15,882,216 80,400
2025-06-30 $360,774,808 1,826,338
2025-06-30 $24,159,142 122,300
2025-03-31 $63,181,000 308,200
2025-03-31 $227,960,000 1,112,000
2025-03-31 $404,893,860 1,975,092
2024-12-31 $145,302,165 632,987
2024-12-31 $47,792,310 208,200
2024-12-31 $73,639,640 320,800
2024-09-30 $137,670,499 495,182
2024-09-30 $241,460,370 868,500
2024-09-30 $49,404,154 177,700
2024-06-30 $28,613,571 114,523
2024-06-30 $364,081,420 1,457,200
2024-06-30 $63,561,840 254,400
2024-03-31 $90,351,942 361,813
2024-03-31 $246,548,556 987,300
2024-03-31 $39,505,704 158,200
2023-12-31 $31,259,817 135,125
2023-12-31 $77,036,220 333,000
2023-12-31 $61,143,162 264,300
2023-09-30 $31,716,328 144,200
2023-09-30 $69,085,289 314,100
2023-09-30 $325,660,270 1,480,632
2023-06-30 $22,702,132 106,700
2023-06-30 $204,519,189 961,240
2023-06-30 $9,723,406 45,700
2023-03-31 $50,005,804 223,800
2023-03-31 $58,697,609 262,700
2023-03-31 $102,840,132 460,259
2022-12-31 $20,588,872 87,500
2022-12-31 $107,862,161 458,400
2022-12-31 $145,866,867 619,915
2022-09-30 $78,883,782 344,500
2022-09-30 $14,517,363 63,400
2022-09-30 $51,361,929 224,307
2022-06-30 $3,236,425 14,400
2022-06-30 $20,160,236 89,700
2022-06-30 $104,490,932 464,917
2022-03-31 $3,146,536 12,100
2022-03-31 $113,006,411 434,566

Report a Problem

Category
Description
Email (optional, for follow-up)